Clear Investment Research’s Exelixis EXEL Stock Holding History

Clear Investment Research’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-169	Closed	-$4.05K	–	232
2023 Q4	$4.05K	Buy	+169	New	+$3.67K	0.01%	220

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clear Investment Research's EXEL Position: Q1 2024 in Review

Clear Investment Research sold out of Exelixis (EXEL) in Q1 2024, closing a stake of 169 shares — an estimated $4.05K sold.

Clear Investment Research first reported a position in EXEL in Q4 2023 and held it in 1 quarter. The position peaked at $4.05K in Q4 2023. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

Clear Investment Research reported no remaining Exelixis position as of Q1 2024 after selling out during the quarter.
Clear Investment Research sold 169 Exelixis shares in Q1 2024, an estimated $4.05K.
Clear Investment Research first reported a position in Exelixis in Q4 2023 and held it in 1 quarter.
Clear Investment Research's Exelixis position peaked at $4.05K in Q4 2023.
422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Clear Investment Research's 13F filing for Q1 2024, filed 2 May 2024.